Enhancing the clinical translation of stem cell models by focusing on standardization and international regulatory cooperation  

作　　者：Wei Wang An-Ran Song Hong-Wen Liu Yi-Kai Li 

机构地区：[1]Department of Traditional Chinese Medicine,Youyang People’s Hospital,Chongqing 409800,China [2]School of Traditional Chinese Medicine,Southern Medical University,Guangzhou 510515,Guangdong Province,China

出　　处：《World Journal of Stem Cells》2025年第4期155-157,共3页世界干细胞杂志(英文)

摘　　要：The article by Granjeiro et al provided a thorough review of the role of stem cell models in the development of advanced therapy medicinal products.It emphasized the potential of stem cell models to refine preclinical studies and align with regulatory requirements for clinical applications.This article introduced a new perspective on enhancing the transition of stem cell research into clinical practice,focusing on the importance of international regulatory harmonization and the need for standardization in stem cell-based therapies.

关 键 词：Stem cell models Advanced therapy medicinal products Tissue engineering Preclinical studies Clinical translation 

分 类 号：R73[医药卫生—肿瘤]